Wednesday, February 10, 2010, 6:32pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

BioMimetic Therapeutics Inc. (BMTI)

At 5:00AM SGT: 11.86 USD   0.00 (0.00%)  
 MORE ON BMTI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BioMimetic Therapeutics, Inc. (NGM:BMTI) Delayed quote dataEdit
Last Trade:11.86 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:11.86
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:21.60
Day's Range:N/A - N/A
52wk Range:6.52 - 15.81
Volume:0
Avg Vol (3m):88,976.2
Market Cap:258.44M
P/E (ttm):N/A
EPS (ttm):-1.75
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add BMTI to Portfolio   Download Data

 HEADLINES 
•How the Brokers Stack Up
at Barrons.com (Sat, Feb 6)
•BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
•BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened
Business Wire (Tue, Feb 2)
•BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
EDGAR Online (Fri, Jan 8)
•BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB
Business Wire (Thu, Jan 7)
•BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events
EDGAR Online (Thu, Dec 24)
•[$$] 13D Filings
at Barrons.com (Sat, Dec 12)
•BioMimetic Therapeutics Ships Augment Bone Graft to Canadian Distributor
Business Wire (Sat, Dec 12)
•BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 10)
•Novo A/S Implements 10b5-1 Trading Plan for Purchase of Additional BioMimetic Therapeutics Shares
Business Wire (Wed, Dec 9)
More Headlines for BMTI...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.55
EPS Est (in 2 years) (Dec-10) :-1.63
Avg Rec (current)*:1.4
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
BioMimetic Therapeutics, Inc. develops and commercializes regenerative protein therapeutic-device combination products. Its products are primarily used for bone and tissue regeneration for the repair and healing of musculoskeletal injuries and con...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices